Mj. Kayath et al., PREVALENCE AND MAGNITUDE OF OSTEOPENIA ASSOCIATED WITH INSULIN-DEPENDENT DIABETES-MELLITUS, Journal of diabetes and its complications, 8(2), 1994, pp. 97-104
The authors evaluated the prevalence, magnitude, and contributing fact
ors for osteopenia in insulin-dependent diabetes mellitus (IDDM). We m
easured bone mineral density (BMD) in the lumbar spine and femoral reg
ion in 90 patients aged 18-54 years with IDDM using dual-energy x-ray
absorptiometry. The blood-glucose control, insulin dosage, duration of
disease, and presence of chronic complications of diabetes were evalu
ated. Serum ionized calcium, magnesium, phosphorus, alkaline phosphata
se (ALP), 25-hydroxycholecalciferol, immunoreactive parathyroid hormon
e (iPTH), and urinary calcium, phosphorus, and hydroxyproline were als
o analyzed. Thirty-one patients (34%) were classified as having a redu
ced BMD (less than 2 SD below the mean). The comparison between normal
and low BMD patients showed that the osteopenics had a tendency to be
younger (median, 28 years versus 32 years), showed a higher mean plas
ma glucose (15.5 +/- 5.0 mmol/L versus 12.9 +/- 3.8 mmol/L; p = 0.018)
, longer duration of disease (11.2 +/- 2.1 years versus 5.0 +/- 1.3 ye
ars; p = 0.004), and needed a higher insulin dosage (56 +/- 17} U/day
versus 43 +/- 16 U/day; p < 0.001). There was a positive correlation b
etween mean glucose levels, duration of disease, insulin dosage, and b
one-mass decrease. A higher incidence of chronic complications, mainly
retinopathy (58% versus 25%) and neuropathy (52% versus 22%) was foun
d in the low BMD group. There was no alteration of serum calcium, phos
phorus, iPTH, 25-hydroxycholecalciferol, and urinary calcium and phosp
horus. The ALP levels were significantly higher in the osteopenic grou
p, and magnesium and hydroxyproline levels were lower in the whole dia
betic group, but these measurements did not correlate with BMD reducti
on. Osteopenia should be considered as a chronic complication of poorl
y controlled patients, and is associated with longer disease duration
and other IDDM chronic complications. (Journal of Diabetes and Its Com
plications 8;2:97-104, 1994.)